Chengda Pharmaceuticals Co., Ltd.

Chengda Pharmaceuticals Co., Ltd. faced notable stock volatility on March 23, 2026, with a significant decline amid a broader market downturn. Despite a strong annual performance, the company reported concerning financial metrics, including low profitability and declining sales, raising questions about its operational efficiency and future growth.

Chengda Pharmaceuticals Co., Ltd. saw a notable increase in stock performance on March 10, 2026, reaching an intraday high. The company has outperformed the China Shanghai Composite over the past week and month, though it faces challenges with management efficiency and has reported negative results for four consecutive quarters.

Chengda Pharmaceuticals Co., Ltd. saw a significant rise in stock price on February 24, 2026, contrasting with a decline in the China Shanghai Composite index. Despite recent gains, the company faces long-term challenges, including declining net sales and a substantial net loss for the first half of the year.